PIPELINE

We develop diagnostic solutions for a wide range of diseases spanning diverse clinical domains. Our discovery and validation processes leverage proprietary, untargeted LC-MS-based multi-OMICS methods. Once validated, final diagnostic tests are implemented using targeted LC-MS techniques or immunoassays, before progressing to CLIA/LDT certifications and FDA trials ahead of commercial launch.